Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoglycaemia unawareness

G B Bolli1

  • 1University of Perugia, Italy. gbolli@dimisem.med.unipg.it

Diabetes & Metabolism
|October 29, 1997
PubMed
Summary
This summary is machine-generated.

Hypoglycaemia unawareness in insulin-dependent diabetes mellitus (IDDM) can be reversed by preventing low blood sugar. This restores warning symptoms and adrenaline responses, crucial for safe intensive diabetes management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS.

Acta diabetologica·2021
Same author

Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503].

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) - a review of evidence and clinical interpretation.

Diabetes & metabolism·2018
Same author

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.

Diabetes & metabolism·2018
Same author

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017
Same journal

Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.

Diabetes & metabolism·2026
Same journal

Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors.

Diabetes & metabolism·2026
Same journal

Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome.

Diabetes & metabolism·2026
Same journal

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same journal

Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study.

Diabetes & metabolism·2026
Same journal

Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetes.

Diabetes & metabolism·2026
See all related articles

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Neuroscience

Background:

  • Hypoglycaemia unawareness is a common complication in insulin-dependent diabetes mellitus (IDDM).
  • It involves a diminished perception of warning symptoms of low blood glucose, leading to neuroglycopenia.
  • This syndrome is linked to impaired counterregulatory hormone responses, particularly adrenaline.

Purpose of the Study:

  • To investigate the mechanisms behind hypoglycaemia unawareness in IDDM.
  • To explore the role of brain glucose transport and counterregulatory responses.
  • To evaluate strategies for preventing and managing hypoglycaemia unawareness.

Main Methods:

  • Review of existing animal and human studies on hypoglycaemia unawareness.
  • Analysis of the impact of recurrent or chronic hypoglycaemia on brain glucose transport.

Related Experiment Videos

  • Assessment of the effects of hypoglycaemia prevention programs on warning symptoms and counterregulation.

    • Main Results:

    • Recurrent hypoglycaemia increases brain glucose transport, contributing to unawareness.
    • Meticulous prevention of hypoglycaemia can restore warning symptoms and adrenaline responses, especially in short-term IDDM.
    • Recovery of these responses is less complete in long-term IDDM.

    Conclusions:

    • Hypoglycaemia unawareness is primarily caused by increased brain glucose transport due to recurrent low blood sugar.
    • Preventing hypoglycaemia is key to restoring warning symptoms and counterregulatory responses.
    • Combining intensive therapy with hypoglycaemia prevention programs allows for safe, effective IDDM management while minimizing unawareness and complications.